GNPXVSMRNA• 6 Months (Normalized)
GNPX vs MRNA (Genprex Inc. vs Moderna Inc.)
Showing Closing Date Range from Mar, 18 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GNPX Performance $3.45
-92.2%
Genprex Inc.
Normalized Baseline0.00%
MRNA Performance $146.69
+179.94%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-272.14%
MRNA outperforming by 272.14%
GNPXMRNA
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GNPX MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | GNPX Price | GNPX Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $3.45 | -92.20% | $146.69 | +179.94% | -272.14% |
| Sep 11, 2026 | $3.35 | -92.42% | $143.97 | +174.75% | -267.17% |
| Sep 10, 2026 | $3.35 | -92.42% | $136.62 | +160.73% | -253.15% |
| Sep 09, 2026 | $3.43 | -92.24% | $135.61 | +158.80% | -251.04% |
| Sep 08, 2026 | $3.54 | -91.99% | $140.33 | +167.81% | -259.80% |
| Sep 04, 2026 | $3.50 | -92.09% | $145.55 | +177.77% | -269.86% |
| Sep 03, 2026 | $3.43 | -92.25% | $148.87 | +184.10% | -276.35% |
| Sep 02, 2026 | $3.51 | -92.06% | $150.81 | +187.81% | -279.87% |
| Sep 01, 2026 | $3.55 | -91.97% | $154.27 | +194.41% | -286.38% |
| Aug 31, 2026 | $3.71 | -91.61% | $140.34 | +167.82% | -259.43% |
| Aug 28, 2026 | $3.67 | -91.70% | $137.99 | +163.34% | -255.04% |
| Aug 27, 2026 | $3.61 | -91.84% | $142.77 | +172.46% | -264.30% |
| Aug 26, 2026 | $3.97 | -91.02% | $149.66 | +185.61% | -276.63% |
| Aug 25, 2026 | $4.00 | -90.95% | $158.83 | +203.11% | -294.06% |
| Aug 24, 2026 | $4.02 | -90.91% | $138.89 | +165.06% | -255.97% |
Page 1 of 9